Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B McInnes

Showing results (371-380 of 537) with videos related to

Pageof 54
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2023
IĸB Protein BCL3 as a Controller of Osteogenesis and Bone HealthHussain Jaffery, Carmen Huesa, Sabarinadh Chilaka, et al.
The British Journal of Dermatology|April 14, 2019
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidityK A Bain, E McDonald, F Moffat, et al.
Frontiers in Immunology|July 14, 2017
Full Length Interleukin 33 Aggravates Radiation-Induced Skin ReactionOlga Kurow, Benjamin Frey, Louis Schuster, et al.
Clinical Epigenetics|April 9, 2020
Differential CpG DNA methylation in peripheral naïve CD4<sup>+</sup> T-cells in early rheumatoid arthritis patientsR Pitaksalee, A N Burska, S Ajaib, et al.
Annals of the Rheumatic Diseases|September 13, 2011
Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationM H Wenink, K C M Santegoets, A M Platt, et al.
RMD Open|October 19, 2021
Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 studyIain B McInnes, Koji Kato, Marina Magrey, et al.
ACR Open Rheumatology|March 7, 2023
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 StudiesDennis McGonagle, Iain B McInnes, Atul Deodhar, et al.
Lancet (London, England)|March 18, 2020
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trialPhilip J Mease, Proton Rahman, Alice B Gottlieb, et al.
Annals of the Rheumatic Diseases|December 17, 2013
Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patientsS Kelly, F Humby, A Filer, et al.
Blood|January 25, 2012
A novel method to allow noninvasive, longitudinal imaging of the murine immune system in vivoVivienne B Gibson, Robert A Benson, Karen J Bryson, et al.
Pageof 54

Showing results (371-380 of 537) with videos related to

Sort By:
Pageof 54
Arthritis & Rheumatology (Hoboken, N.J.)|July 6, 2023
IĸB Protein BCL3 as a Controller of Osteogenesis and Bone HealthHussain Jaffery, Carmen Huesa, Sabarinadh Chilaka, et al.
The British Journal of Dermatology|April 14, 2019
Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidityK A Bain, E McDonald, F Moffat, et al.
Frontiers in Immunology|July 14, 2017
Full Length Interleukin 33 Aggravates Radiation-Induced Skin ReactionOlga Kurow, Benjamin Frey, Louis Schuster, et al.
Clinical Epigenetics|April 9, 2020
Differential CpG DNA methylation in peripheral naïve CD4<sup>+</sup> T-cells in early rheumatoid arthritis patientsR Pitaksalee, A N Burska, S Ajaib, et al.
Annals of the Rheumatic Diseases|September 13, 2011
Abatacept modulates proinflammatory macrophage responses upon cytokine-activated T cell and Toll-like receptor ligand stimulationM H Wenink, K C M Santegoets, A M Platt, et al.
RMD Open|October 19, 2021
Upadacitinib in patients with psoriatic arthritis and an inadequate response to non-biological therapy: 56-week data from the phase 3 SELECT-PsA 1 studyIain B McInnes, Koji Kato, Marina Magrey, et al.
ACR Open Rheumatology|March 7, 2023
Guselkumab, a Selective Interleukin-23 p19 Subunit Inhibitor, Resolves Dactylitis in Patients With Active Psoriatic Arthritis: Pooled Results Through Week 52 From Two Phase 3 StudiesDennis McGonagle, Iain B McInnes, Atul Deodhar, et al.
Lancet (London, England)|March 18, 2020
Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trialPhilip J Mease, Proton Rahman, Alice B Gottlieb, et al.
Annals of the Rheumatic Diseases|December 17, 2013
Ultrasound-guided synovial biopsy: a safe, well-tolerated and reliable technique for obtaining high-quality synovial tissue from both large and small joints in early arthritis patientsS Kelly, F Humby, A Filer, et al.
Blood|January 25, 2012
A novel method to allow noninvasive, longitudinal imaging of the murine immune system in vivoVivienne B Gibson, Robert A Benson, Karen J Bryson, et al.
Pageof 54